1. Biosafety considerations for viral vector gene therapy: an explanation and guide for the average everyday-hero pharmacist;Hernandez;J Pharm Pract,2023
2. European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of gene medicines;Vulto;Eur J Hosp Pharm,2007
3. European Association of Hospital Pharmacists . Special interest group report: hospital pharmacist’s preparedness for in-vivo gene therapy medicinal products 2023. Available: https://www.eahp.eu/sites/default/files/eahp_sig_gene_therapy_report.pdf [Accessed 15 Apr 2024].
4. The AGREE Next Steps Consortium . Appraisal of guidelines for research and evaluation II. 2017. Available: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf [Accessed 15 Apr 2024].
5. European Medicines Agency . Reflection paper on classification of advanced therapy medicinal products 2015. 2015. Available: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-classification-advanced-therapy-medicinal-products_en-0.pdf [Accessed 15 Apr 2024].